Oura Health Files for $15.6B IPO as It Enters Public Markets
Oura Inc., the smart ring company, is preparing to go public in the U.S. with an initial public offering (IPO) targeting a fully diluted valuation of approximately $15.62 billion. The firm plans to price its shares next week and list on Nasdaq under the symbol OURA. If priced at the top end of its expected range ($40–$44), the IPO could raise up to $2.2 billion by selling 50 million shares. Oura reported strong growth, with revenue rising about 74% year-over-year in the nine months ending June 30 to reach $1.21 billion and projecting a total of around 5.7 million paid members for fiscal 2026—a 96% increase from the prior year. The company has attracted interest from major investors, including Eli Lilly (LLY) committing up to $100 million and Dragoneer Investment Group up to $300 million. Goldman Sachs, Morgan Stanley, and JPMorgan are underwriting the IPO. However, Oura faces a class-action lawsuit over alleged misrepresentation of its sleep-tracking accuracy.
Topics: consumer tech investment IPO valuation